Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo: A Quasi-Experimental Study [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update outlines a Phase 2/Phase 3 quasi-experimental study assessing whether hUCMSC-secretome delivered by microneedling or intradermal micr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hUCMSC-Secretome (human umbilical cord mesenchymal stem cell secretome)

Snippet

Sponsor: Yohanes Firmansyah, dr, MH, MM | Conditions: Vitiligo | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING